Jacob Vogan

Jacob Vogan is a molecular biologist and the Co-founder of CB Therapeutics, a biotechnology company based in California. Prior to his entrepreneurial career, he earned a PhD and completed a postdoctoral research fellowship at the University of California, Berkeley, where he developed deep domain expertise in molecular biology, telomere dynamics, and the science of aging. At CB Therapeutics, Vogan directs platform development initiatives that leverage synthetic biology and precision yeast engineering to manufacture rare bioactive compounds at a scalable commercial level. His technical work centers on utilizing advanced fermentation processes to biosynthesize complex therapeutic molecules, specifically targeting cannabinoids, psychedelics, and peptides for the broader wellness and medical sectors. Vogan's current focus remains on bridging his foundational academic research in cellular biology with scalable commercial biotechnology applications to advance the broader fields of longevity science and therapeutic development.